The objective of this study was to evaluate changes in tumor grade, mitotic count, Ki67, AgNOR, and AgNORxKi67 scores following short-course anti-inflammatory neoadjuvant prednisone in canine patients with cutaneous mast cell tumors. This evidence concerns the gene MKI67 and mast cell neoplasm.